CSF3 and acute myeloid leukemia: As conventional salvage protocols in AML contained anthracyclines such as idarubicin were not feasible in this child due to cardiac dysfunction, he was treated with one cycle each of high-dose cytarabine (18 g/m2), venetoclax-azacitidine, and fludarabine, cytarabine, granulocyte colony-stimulating factor (GCSF) (FLAG)-bortezomib.